Top Markets
Coin of the day
Mizuho Medy Co.,Ltd. Mizuho Medy Co.,Ltd.

Mizuho Medy Co.,Ltd.

4595
Rang in Aktien #18063
Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd.... Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd. specializes in the research, development, production, and distribution of in-vitro diagnostic solutions, complemented by scientific and technical information services. While its primary operations are in Japan, the company maintains an international presence through import and export activities, extending its reach to countries including the United States, Belgium, Finland, the Netherlands, Taiwan, and Thailand. Its extensive product lineup includes a wide array of immunoassay test kits designed for detecting pathogens such as influenza viruses, RS virus, human metapneumovirus, Streptococcus pneumoniae, Legionella, Mycoplasma pneumoniae, adenovirus, rotavirus, norovirus, and Group A streptococcus. Additionally, Mizuho Medy offers kits for pregnancy, ovulation, and fecal occult blood screening. The company also provides advanced tools like gene analysis instruments and specialized diagnostic kits for SARS-CoV-2 detection and Mycoplasma pneumoniae nucleic acid analysis.
Aktienkurs
$11.23
Marktkapitalisierung
$214.01M
Veränderung (1 Tag)
-0.06%
Veränderung (1 Jahr)
5.75%
Land
JP
Handel Mizuho Medy Co.,Ltd. (4595)

Kategorie

EPS für Mizuho Medy Co.,Ltd. (4595)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Mizuho Medy Co.,Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Mizuho Medy Co.,Ltd. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber